Topics

Johnson & Johnson reports positive results for Stelara using "treat-to-target" approach in Phase III Crohn's disease trial https://www.firstwordpharma.com/node/1700915?tsid=28®ion_id=6 …

09:32 EST 14 Feb 2020 | FirstWord Pharma

Johnson & Johnson reports positive results for Stelara using "treat-to-target" approach in Phase III Crohn's disease trial https://www.firstwordpharma.com/node/1700915?tsid=28&region_id=6 …

Original Article: Johnson & Johnson reports positive results for Stelara using "treat-to-target" approach in Phase III Crohn's disease trial https://www.firstwordpharma.com/node/1700915?tsid=28®ion_id=6 …

NEXT ARTICLE

More From BioPortfolio on "Johnson & Johnson reports positive results for Stelara using "treat-to-target" approach in Phase III Crohn's disease trial https://www.firstwordpharma.com/node/1700915?tsid=28®ion_id=6 …"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...